More than 20 faculty have research programs that encompass various aspects of neuropharmacology. Emory University is one of the world's premier universities for those interested in the neurobiology and treatment of neuropsychiatric disorders, substance abuse and epilepsy. Indeed, there are 12 faculty members in our program (more than any other university) who are members of the prestigious American College of Neuropsychopharmalogy (http://www.acnp.org). Strengths include the neurobiological substrates of social and affiliative behaviors, fear, anxiety, stress and depression. These strengths are equally complimented by expertise on the pharmacology of anxiolytic, antidepressant and antipsychotic drugs. Studies of G proteins-coupled signal transduction pathways as well as behavioral, molecular and physiological studies of drugs of abuse and glutamate receptor functions in epilepsy and neurodegeneration are additional assets of this program.

Faculty with interests in Neuropharmacology:

• Abercrombie, Ronald F. [ron@physio.emory.edu]. Regulation of intracellular calcium and interactions between calcium and pH in neurons.
• Dingledine, Raymond [rdingle@bimcore.cc.emory.edu]
  Genetic control of glutamate receptor function.
• Gordon, Frank J. [fgordon@emory.edu]
  CNS regulation of the immune and cardiovascular systems.
• Hall, Randy, A [rhall@pharm.emory.edu]
  Mechanisms of signal transduction by neurotransmitter and hormone receptors.
• Hepler, John [jhepler@emory.edu]
  Hormone action and second messenger pathways; G-protein signaling; cellular roles for RGS proteins.
• Howell, Leonard [leonard@rmy.emory.edu]
  Behavioral neuropharmacology of CNS stimulants in nonhuman primates.
• Iuvone, P. Michael [miuvone@pharm.emory.edu]
  Circadian rhythms, signal transduction and neuromodulators in the retina.
• Kilts, Clinton [sdpcdk@emory.edu]
  Dr. Kilts is s a psychopharmacologist and neuroscientist focusing on the application of brain imaging technology to the study of normal and abnormal human behavior.
• Kimmel, Heather L [Heather.Kimmel@emory.edu]
  Behavioral pharmacology of cocaine and related psychomotor stimulants in pimates.
• Kuhar, Michael J [mkuhar@rmy.emory.edu]
  Biological basis of drug addiction focusing on drug receptors and novel genes involved in the addiction process.
• Li, Lian [lianli@pharm.emory.edu]
  Molecular basis of neurotransmitter release and pathogenic mechanisms of neurodegenerative diseases.
• Miller, Andrew [amill02@emory.edu]
  Glucocorticoids as mediators of interactions between the CNS and the immune system.
• Miller, Gary W [gwmille@emory.edu]
  Role of environmental and genetic factors in neurological diseases.
• Muly, E. Christopher [ecmuly@rmy.emory.edu]
  Effects of altered dopamine neurotranmission on the architecture of signal transduction proteins in the synapses of the cortex and striatum.
• Neill, Darryl B [darryl@fs1.psy.emory.edu]
  Drugs of abuse; brain reward systems.
• Nemeroff, Charles [cnemero@emory.edu]
  Effects of psychopharmacological agents on brain neuropeptide systems.
• Owens, Michael [mowens@emory.edu]
  Interactions between neuropeptides and clinically efficacious psychotropic drugs; neuropsychopharmacology.
• Papa, Stella [spapa@emory.edu]
  Movement Disorders, particularly, Parkinson's disease, Basal Ganglia physiology and Experimental Therapeutics.
• Smith, Yoland [yolands@rmy.emory.edu]
  Synaptic localization and functional interactions between glutamate and GABA receptors in the CNS.
• Traynelis, Stephen [ecmuly@rmy.emory.edu]
  Control of glutamate receptor activation in stroke, epilepsy, and normal brain function.
• Weinshenker, David [dweinshenker@genetics.emory.edu]
  Drug addiction, Alzheimer's and Parkinson's disease, epilepsy, depression, and hibernation.